Publication Information

{'id': 'https://openalex.org/W2994184523', 'doi': 'https://doi.org/10.1158/1535-7163.targ-19-pr10', 'title': 'Abstract PR10: Tri-complex inhibitors of the oncogenic, GTP-bound form of KRASG12C overcome RTK-mediated escape mechanisms and drive tumor regressions <i>in vivo</i>', 'display_name': 'Abstract PR10: Tri-complex inhibitors of the oncogenic, GTP-bound form of KRASG12C overcome RTK-mediated escape mechanisms and drive tumor regressions <i>in vivo</i>', 'publication_year': 2019, 'publication_date': '2019-12-01', 'ids': {'openalex': 'https://openalex.org/W2994184523', 'doi': 'https://doi.org/10.1158/1535-7163.targ-19-pr10', 'mag': '2994184523'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1535-7163.targ-19-pr10', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S48437117', 'display_name': 'Molecular Cancer Therapeutics', 'issn_l': '1535-7163', 'issn': ['1535-7163', '1538-8514'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5052945974', 'display_name': 'Christopher J. Schulze', 'orcid': 'https://orcid.org/0009-0005-6736-871X'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Christopher J Schulze', 'raw_affiliation_strings': ['Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': 'Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5071778044', 'display_name': 'Alun Bermingham', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Alun Bermingham', 'raw_affiliation_strings': ['Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': 'Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5055494036', 'display_name': 'Tiffany J. Choy', 'orcid': 'https://orcid.org/0000-0001-6501-2123'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Tiffany J Choy', 'raw_affiliation_strings': ['Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': 'Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5007819332', 'display_name': 'James Cregg', 'orcid': 'https://orcid.org/0000-0002-2871-0800'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'James J Cregg', 'raw_affiliation_strings': ['Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': 'Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5019581942', 'display_name': 'Gert Kiss', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Gert Kiss', 'raw_affiliation_strings': ['Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': 'Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5012645194', 'display_name': 'Abby Marquez', 'orcid': 'https://orcid.org/0000-0001-5104-2823'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Abby Marquez', 'raw_affiliation_strings': ['Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': 'Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5112578026', 'display_name': 'Denise F. Reyes', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Denise Reyes', 'raw_affiliation_strings': ['Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': 'Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5084424315', 'display_name': 'Mae Saldajeno-Concar', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Mae Saldajeno-Concar', 'raw_affiliation_strings': ['Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': 'Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5087767215', 'display_name': 'Caroline E. Weller', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Caroline E Weller', 'raw_affiliation_strings': ['Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': 'Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5111780654', 'display_name': 'Daniel M. Whalen', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Daniel M Whalen', 'raw_affiliation_strings': ['Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': 'Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5020727899', 'display_name': 'Yu Chi Yang', 'orcid': 'https://orcid.org/0000-0001-8318-1174'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Yu C Yang', 'raw_affiliation_strings': ['Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': 'Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5040036103', 'display_name': 'Elena S. Koltun', 'orcid': 'https://orcid.org/0009-0005-8720-9097'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Elena S Koltun', 'raw_affiliation_strings': ['Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': 'Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5103986436', 'display_name': 'Robert J. Nichols', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Robert J Nichols', 'raw_affiliation_strings': ['Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': 'Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5057362852', 'display_name': 'Mallika Singh', 'orcid': 'https://orcid.org/0009-0003-0234-1589'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Mallika Singh', 'raw_affiliation_strings': ['Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': 'Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5038156337', 'display_name': 'David Wildes', 'orcid': 'https://orcid.org/0009-0009-3855-7270'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'David Wildes', 'raw_affiliation_strings': ['Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': 'Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5022776516', 'display_name': 'Adrian L. Gill', 'orcid': 'https://orcid.org/0009-0003-0914-4860'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Adrian L Gill', 'raw_affiliation_strings': ['Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': 'Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5066537541', 'display_name': 'Richard L. Hansen', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Richard L Hansen', 'raw_affiliation_strings': ['Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': 'Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5109158285', 'display_name': 'Steve Kelsey', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Steve Kelsey', 'raw_affiliation_strings': ['Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': 'Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5021689661', 'display_name': 'Mark A. Goldsmith', 'orcid': 'https://orcid.org/0000-0001-8833-6841'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Mark A Goldsmith', 'raw_affiliation_strings': ['Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': 'Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5027330002', 'display_name': 'Jacqueline A.M. Smith', 'orcid': 'https://orcid.org/0000-0001-5028-8725'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Jacqueline A.M. Smith', 'raw_affiliation_strings': ['Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': 'Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.739, 'has_fulltext': False, 'cited_by_count': 16, 'citation_normalized_percentile': {'value': 0.622287, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 89, 'max': 90}, 'biblio': {'volume': '18', 'issue': '12_Supplement', 'first_page': 'PR10', 'last_page': 'PR10'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T12620', 'display_name': 'Signaling Pathways in Disease', 'score': 0.9995, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T12620', 'display_name': 'Signaling Pathways in Disease', 'score': 0.9995, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T12505', 'display_name': 'Peptidase Inhibition and Analysis', 'score': 0.9988, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12827', 'display_name': 'Biochemical and Molecular Research', 'score': 0.9903, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [], 'concepts': [{'id': 'https://openalex.org/C207332259', 'wikidata': 'https://www.wikidata.org/wiki/Q769143', 'display_name': 'GTPase', 'level': 2, 'score': 0.6632326}, {'id': 'https://openalex.org/C118716', 'wikidata': 'https://www.wikidata.org/wiki/Q5514725', 'display_name': "GTP'", 'level': 3, 'score': 0.5559509}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.4835298}, {'id': 'https://openalex.org/C95444343', 'wikidata': 'https://www.wikidata.org/wiki/Q7141', 'display_name': 'Cell biology', 'level': 1, 'score': 0.44350204}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.35901558}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.30863005}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.3032204}, {'id': 'https://openalex.org/C181199279', 'wikidata': 'https://www.wikidata.org/wiki/Q8047', 'display_name': 'Enzyme', 'level': 2, 'score': 0.09169069}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1535-7163.targ-19-pr10', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S48437117', 'display_name': 'Molecular Cancer Therapeutics', 'issn_l': '1535-7163', 'issn': ['1535-7163', '1538-8514'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/8', 'display_name': 'Decent work and economic growth', 'score': 0.48}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W2769412055', 'https://openalex.org/W2331905247', 'https://openalex.org/W2276183529', 'https://openalex.org/W2186443916', 'https://openalex.org/W2072932710', 'https://openalex.org/W2008470784', 'https://openalex.org/W2000236507', 'https://openalex.org/W1976401619', 'https://openalex.org/W1570552209', 'https://openalex.org/W1540219323'], 'abstract_inverted_index': {'Abstract': [0], 'RAS': [1, 17, 116, 218, 251, 414], 'proteins': [2, 18, 97], 'are': [3, 19, 211], 'small': [4], 'GTPases': [5], 'that': [6, 76, 113, 133, 162, 210, 371, 440], 'drive': [7, 204, 517], 'cell': [8, 63, 237, 241, 345, 367], 'proliferation': [9, 306], 'and': [10, 27, 84, 121, 153, 169, 197, 236, 275, 309, 339, 351, 363, 392, 416, 516, 533], 'survival': [11], 'when': [12], 'bound': [13], 'to': [14, 35, 54, 94, 107, 195, 327, 403, 407, 435], 'GTP.': [15], 'Mutant': [16], 'found': [20, 58], 'in': [21, 30, 49, 59, 110, 183, 224, 239, 250, 267, 286, 313, 419, 520], 'approximately': [22], 'one-third': [23], 'of': [24, 61, 71, 82, 92, 127, 140, 160, 187, 206, 222, 259, 296, 307, 332, 335, 359, 377, 384, 389, 395, 412, 423, 444, 505, 510, 525], 'human': [25], 'cancers,': [26], 'exist': [28], 'predominantly': [29], 'the': [31, 78, 88, 99, 124, 136, 170, 184, 217, 268, 281, 294, 349, 360, 373, 390, 409, 433, 506, 526], 'GTP-bound': [32, 138, 375, 410, 508], 'state,': [33, 283], 'leading': [34], 'excessive': [36], 'downstream': [37], 'signaling': [38, 120, 235], 'via': [39], 'interaction': [40], 'with': [41, 190, 216, 279, 322], 'effectors': [42], 'such': [43], 'as': [44], 'RAF.': [45], 'A': [46, 174, 498], 'KRAS': [47, 188, 378], 'mutation': [48], 'which': [50], 'glycine-12': [51], 'is': [52, 57, 105, 276, 288, 301, 315], 'mutated': [53], 'cysteine': [55], '(KRASG12C)': [56], '11-12%': [60], 'non-small': [62], 'lung': [64], 'cancers.': [65], 'Recently,': [66], 'multiple': [67], 'potent,': [68], 'covalent': [69, 393, 421], 'inhibitors': [70, 159, 178, 202, 231, 300, 370, 398, 431, 504], 'KRASG12C': [72, 96, 141, 168, 244, 270, 385, 406, 511], 'have': [73, 156, 432], 'been': [74], 'reported': [75], 'target': [77, 372, 408], 'inactive,': [79, 100], 'GDP-bound': [80, 101], 'form': [81, 139, 376, 509], 'KRASG12C,': [83], 'thus': [85, 379], 'rely': [86], 'on': [87, 530], 'residual': [89], 'intrinsic': [90], 'hydrolysis': [91], 'GTP': [93], 'cycle': [95], 'through': [98], 'state.': [102], 'This': [103], 'mechanism': [104], 'vulnerable': [106], 'adaptive': [108, 437], 'responses': [109], 'cancer': [111, 240], 'cells': [112, 312], 'can': [114], 'activate': [115], 'by': [117, 290], 'increasing': [118], 'upstream': [119], 'further': [122], 'increase': [123], 'relative': [125], 'abundance': [126], 'KRASG12C(GTP)': [128, 161, 230, 261, 323, 341], 'over': [129], 'KRASG12C(GDP).': [130], 'An': [131], 'inhibitor': [132, 262, 324, 338, 342, 353], 'directly': [134, 426], 'targets': [135], 'active,': [137, 374], 'would': [142], 'overcome': [143, 436, 512], 'this': [144], 'limitation.': [145], 'Drawing': [146], 'inspiration': [147], 'from': [148, 214], 'natural': [149], 'products': [150], 'like': [151], 'cyclosporine': [152], 'rapamycin,': [154], 'we': [155, 417], 'developed': [157], 'tri-complex': [158, 397, 430], 'promote': [163], 'a': [164, 260, 318, 336, 340, 356, 381], 'ternary': [165, 208], 'complex': [166], 'between': [167], 'abundant': [171], 'immunophilin': [172], 'cyclophilin': [173], '(CypA).': [175], 'These': [176], 'sanglifehrin-inspired': [177], 'exploit': [179], 'significant': [180], 'non-covalent': [181, 391], 'interactions': [182, 394], 'SWI/SWII': [185], 'region': [186], 'combined': [189], 'an': [191, 400], 'electrophilic': [192], 'cysteine-targeted': [193], 'warhead': [194], 'potently': [196], 'irreversibly': [198], 'inhibit': [199], 'KRASG12C(GTP).': [200], 'The': [201, 330], 'selectively': [203], 'formation': [205], 'KRASG12C-inhibitor-CypA': [207], 'complexes': [209], 'sterically': [212], 'prevented': [213], 'interacting': [215], 'Binding': [219], 'Domain': [220], '(RBD)': [221], 'BRAF': [223], 'biochemical': [225], 'studies.': [226], 'In': [227, 256, 304, 347], 'cellular': [228], 'models,': [229], 'attenuate': [232], 'both': [233], 'RAS-MAPK': [234, 446], 'viability': [238], 'lines': [242], 'bearing': [243], 'mutations,': [245], 'but': [246], 'not': [247, 365], 'other': [248, 253], 'mutations': [249], 'or': [252], 'pathway': [254, 447], 'oncoproteins.': [255], 'vivo': [257, 521], 'administration': [258], 'drives': [263], 'dose-dependent': [264], 'tumor': [265, 518], 'regressions': [266, 519], 'NCI-H358': [269, 308], 'NSCLC': [271], 'xenograft': [272], 'mouse': [273], 'model': [274], 'well-tolerated.': [277], 'Consistent': [278], 'targeting': [280, 427], 'KRAS(GTP)': [282], 'inhibitory': [284], 'activity': [285, 295], 'vitro': [287, 314, 420], 'unaffected': [289], 'RTK': [291], 'activation,': [292], 'whereas': [293], 'first': [297], 'generation': [298, 383], 'KRASG12C(GDP)': [299, 328, 352], 'significantly': [302, 319], 'attenuated.': [303], 'addition,': [305], 'MIA': [310], 'PaCa-2': [311], 'suppressed': [316], 'for': [317], 'longer': [320], 'duration': [321], 'treatment': [325], 'compared': [326], 'inhibitors.': [329], 'combination': [331, 354], 'sub-maximal': [333], 'concentrations': [334], 'MEK': [337, 350], 'drove': [343], 'pronounced': [344], 'death.': [346, 368], 'contrast,': [348], 'evoked': [355], 'modest': [357], 'enhancement': [358], 'antiproliferative': [361], 'effects': [362], 'does': [364], 'cause': [366], 'Tri-complex': [369, 503], 'represent': [380], 'second': [382], 'inhibitor.': [386], 'Chemical': [387], 'modulation': [388], 'our': [396], 'provides': [399], 'exciting': [401], 'opportunity': [402], 'step': [404], 'beyond': [405], 'state': [411], 'additional': [413], 'variants,': [415], 'demonstrate': [418], 'inhibition': [422, 443], 'KRASG13C.': [424], 'By': [425], 'active': [428], 'RAS-GTP,': [429], 'potential': [434], 'resistance': [438], 'mechanisms': [439, 515], 'emerge': [441], 'following': [442], 'aberrant': [445], 'activation.': [448], 'Citation': [449], 'Format:': [450], 'Christopher': [451], 'J': [452, 457, 460, 483], 'Schulze,': [453], 'Alun': [454], 'Bermingham,': [455], 'Tiffany': [456], 'Choy,': [458], 'James': [459], 'Cregg,': [461], 'Gert': [462], 'Kiss,': [463], 'Abby': [464], 'Marquez,': [465], 'Denise': [466], 'Reyes,': [467], 'Mae': [468], 'Saldajeno-Concar,': [469], 'Caroline': [470], 'E': [471], 'Weller,': [472], 'Daniel': [473], 'M': [474], 'Whalen,': [475], 'Yu': [476], 'C': [477], 'Yang,': [478], 'Elena': [479], 'S': [480], 'Koltun,': [481], 'Robert': [482], 'Nichols,': [484], 'Mallika': [485], 'Singh,': [486], 'David': [487], 'Wildes,': [488], 'Adrian': [489], 'L': [490, 493], 'Gill,': [491], 'Richard': [492], 'Hansen,': [494], 'Steve': [495], 'Kelsey,': [496], 'Mark': [497], 'Goldsmith,': [499], 'Jacqueline': [500], 'A.M.': [501], 'Smith.': [502], 'oncogenic,': [507], 'RTK-mediated': [513], 'escape': [514], '[abstract].': [522], 'In:': [523], 'Proceedings': [524], 'AACR-NCI-EORTC': [527], 'International': [528], 'Conference': [529], 'Molecular': [531], 'Targets': [532], 'Cancer': [534, 545], 'Therapeutics;': [535], '2019': [536], 'Oct': [537], '26-30;': [538], 'Boston,': [539], 'MA.': [540], 'Philadelphia': [541], '(PA):': [542], 'AACR;': [543], 'Mol': [544], 'Ther': [546], '2019;18(12': [547], 'Suppl):Abstract': [548], 'nr': [549], 'PR10.': [550], 'doi:10.1158/1535-7163.TARG-19-PR10': [551]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2994184523', 'counts_by_year': [{'year': 2024, 'cited_by_count': 2}, {'year': 2023, 'cited_by_count': 5}, {'year': 2022, 'cited_by_count': 5}, {'year': 2021, 'cited_by_count': 4}], 'updated_date': '2024-12-07T15:00:41.034199', 'created_date': '2019-12-13'}